Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance.
- befree-20150227 importedOn "2015-02-27" NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance.
- NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_assertion wasGeneratedBy ECO_0000203 NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance.
- NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_assertion wasDerivedFrom befree-20150227 NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance.
- NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_assertion SIO_000772 24286619 NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance.
- NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_assertion evidence source_evidence_literature NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance.
- NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_assertion description "[Over-expression of nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB) and tumor-necrosis factor alpha (TNFα) treatment significantly increased the USP24 promoter activity, mRNA expression and protein level in human HEK293 cells, mouse N2a cells and human neuroblastoma SH-SY5Y cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871088.RAl6KcjrC0d8Vq8-hADWrDKM1DxWgBLatUmnmbRNuMg6Q130_provenance.